Diabetes, Metabolic Syndrome and Obesity (Dec 2021)
Role of Diabetes Mellitus in Acute Coronary Syndrome Patients with Heart Failure and Midrange Ejection Fraction Who Have Undergone Percutaneous Coronary Intervention: A 3-Year Case-Series Follow-Up Retrospective Study
Abstract
Lieyou Li,1,* Ganyang Li,2,* Huang Chen,1 Zhihai Feng,1 Lin Zhang,1 Lianglong Chen,1 Lin Fan1 1Department of Cardiology, Fujian Medical University Union Hospital Institute of Coronary Heart Disease, Fuzhou, Fujian, People’s Republic of China; 2Department of Cardiology, Longyan First Hospital Affiliated with Fujian Medical University, Longyan, Fujian, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lin Fan Tel +86 591 8335-7896Fax +86 591 83308713Email [email protected]: Data are limited on the effect of diabetes mellitus (DM) on the prognosis of acute coronary syndrome (ACS) patients with heart failure with midrange ejection fraction (HFmrEF) who have undergone percutaneous coronary intervention (PCI). This study aimed to investigate the relationship between type 2 DM (T2DM) and 3-year outcomes in such a population.Methods: A total of 377 ACS patients with HFmrEF (left ventricular EF 40%– 49%) who had undergone PCI (132 diabetic and 245 nondiabetic patients) were included in the analysis. The primary outcome was a composite end point of all-cause death or HF rehospitalization. Cox proportional-hazard regression analysis and Kaplan–Meier tests were used to assess the effect of DM on the primary outcome. Sensitivity analysis was conducted with propensity score–matching analysis.Results: During a follow-up of 3 years, diabetic patients had higher incidence of the primary outcome than nondiabetic patients (96.1 vs 44.6 per 1,000 patient-years, incidence ratio 2.301, 95% CI 1.334– 3.969; P=0.002). Multivariate analysis showed that DM was associated with a significant increase in the composite outcome of all-cause death or HF rehospitalization (adjusted HR 2.080, 95% CI 1.115– 3.878; P=0.021). Sensitivity analysis further confirmed that DM was an independent prognostic factor of long-term adverse outcomes for ACS patients with HFmrEF who had undergone PCI (adjusted HR 3.792, 95% CI 1.802– 7.980; P< 0.001).Conclusion: Among ACS patients with HFmrEF who had undergone PCI, T2DM comorbidity was significantly associated with worse long-term outcomes.Keywords: diabetes mellitus, acute coronary syndrome, heart failure with midrange ejection fraction, percutaneous coronary intervention, outcome
